The kit is designed for quantitative detection of the hepatitis B virus DNA in patients with suspected infection and determination of viral load in patients with the detected hepatitis B virus to choose an appropriate therapy and evaluate its effectiveness.
The kit is designed for qualitative and quantitative detection of hepatitis D virus RNA.
The kit is intended for diagnostics of the respiratory viral infection caused by the SARS-CoV-2 coronavirus.
The kit is designed for detection of DNA of 5 pathogens of urogenital infections.
The reagent kit is intended for early non-invasive diagnosis of prostate cancer by detecting the chimeric TMPRSS2-ERG gene and determining the expression level of the PCA3 gene, specific for prostate cancer, in relation to the level of the KLK3 gene, characteristic only for prostate tissue.